30 January 2017

The Rubicon grant is awarded either to talented researchers that go abroad for two years to gain new research experiences or to attract talent from abroad to perform research in the Netherlands.

The Rubicon grant is awarded either to talented researchers that go abroad for two years to gain new research experiences or to attract talent from abroad to perform research in the Netherlands. 

For the Radboud Institute of Molecular Life Sciences 2 researchers received a Rubicon Grant. undefined
undefined
Bettina Weigelin, working at the Dept. of  Cell Biology goes to MD Anderson Cancer Center, Genitourinary Medical Oncology in the USA for 24 months. 

Illuminating the hiding spots using intravital microscopy: targeting immune evasion of prostate cancer lesions in bone.
Cancer immunotherapy has the potential to cure but prostate cancer bone metastases are resistant to immune attack. Bettina Weigelin will use in-depth analysis and multiphoton microscopy to visualise the battle between immune cells and tumour cells in the bone so that strategies to revert cancer resistance can be identified.  
undefined
Lotte de Winde, working at the Dept. of Tumor Immunology, goes to University College London, MRC Laboratory for Molecular Cell Biology in the UK for 24 months.

It takes three to tango: Dynamic cell-cell interactions in the lymph node.
During an infection the immune system defends our body. Special fibroblasts in the lymph node enable immune cells to communicate with each other as a result of which the immune response is activated. In this study the dynamic interaction between the different types of cells in the lymph node will be investigated.

Related news items


Joint research in regional hospitals New research projects from promotion fund

22 November 2022

Four research projects have been honored in the promotion fund of the Radboudumc and four regional hospitals. The research projects, which are a collaboration between CWZ, Jeroen Bosch Hospital, Rijnstate, Sint Maartenskliniek and the Radboudumc will receive a contribution of 240,000 euros.

read more

Trained immunity’s role in kidney disease

17 November 2022

Researcher(s) Jordi Ochando of the Icahn School of Medicine at Mount Sinai in New York and Raphaël Duivenvoorden of the Department of Nephrology at Radboudumc explain how trained immunity can have detrimental effects in kidney disease and transplantation. 

read more